These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 27683096)

  • 1. Sudden onset of parathyroid hormone-independent severe hypercalcemia from reversal of tumoral calcinosis in a dialysis patient.
    Kamar FB; Mann B; Kline G
    BMC Nephrol; 2016 Sep; 17(1):137. PubMed ID: 27683096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recuperation of severe tumoral calcinosis in a dialysis patient: A case report.
    Westermann L; Isbell LK; Breitenfeldt MK; Arnold F; Röthele E; Schneider J; Widmeier E
    World J Clin Cases; 2019 Dec; 7(23):4004-4010. PubMed ID: 31832402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Periarticular tumoral calcinosis and hypercalcemia in a hemodialysis patient without hyperparathyroidism: a case report.
    Eisenberg B; Tzamaloukas AH; Hartshorne MF; Listrom MB; Arrington ER; Sherrard DJ
    J Nucl Med; 1990 Jun; 31(6):1099-103. PubMed ID: 2348239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of tumoral calcinosis using CAPD combined with hemodialysis with low-calcium dialysate.
    Kuriyama S; Tomonari H; Nakayama M; Kawaguchi Y; Sakai O
    Blood Purif; 1998; 16(1):43-8. PubMed ID: 9513762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resolution of massive uremic tumoral calcinosis with daily nocturnal home hemodialysis.
    Kim SJ; Goldstein M; Szabo T; Pierratos A
    Am J Kidney Dis; 2003 Mar; 41(3):E12. PubMed ID: 12613005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of uremic tumoral calcinosis by optimization of clinical treatment of bone and mineral metabolism disorder.
    Maioli ME; Delfino VDA; Guerra ACDZ; Kunii LF; Frange RFN
    J Bras Nefrol; 2017; 39(2):217-219. PubMed ID: 29069247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of cinacalcet hinders the diagnosis of parathyroid carcinoma in a chronic dialysis patient: a case report.
    Takada D; Tsukamoto T; Fuse M; Kada S; Yanagita M
    BMC Nephrol; 2017 Oct; 18(1):315. PubMed ID: 29047366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parathyroid hormone and parathyroid hormone related protein assays in the investigation of hypercalcemic patients in hospital in a Chinese population.
    Lee JK; Chuang MJ; Lu CC; Hao LJ; Yang CY; Han TM; Lam HC
    J Endocrinol Invest; 1997; 20(7):404-9. PubMed ID: 9309539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uremic tumoral calcinosis in hemodialysis patients: clinicopathological findings and identification of calcific deposits.
    Hamada J; Tamai K; Ono W; Saotome K
    J Rheumatol; 2006 Jan; 33(1):119-26. PubMed ID: 16395759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of parathyroid function in patients with a short history of hemodialysis.
    Nishi H; Sato T; Kurihara T; Kurosawa T; Fukagawa M
    Ther Apher Dial; 2005 Feb; 9(1):39-43. PubMed ID: 15828904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumoral calcinosis in the neck region involving an unusual site in a hemodialysis patient.
    Pan CW; Chen RF
    Laryngoscope; 2016 May; 126(5):E196-8. PubMed ID: 26608820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cinacalcet HCl: a novel treatment for secondary hyperparathyroidism caused by chronic kidney disease.
    Torres PU
    J Ren Nutr; 2006 Jul; 16(3):253-8. PubMed ID: 16825031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular calcification in patients with end-stage renal disease: a century-old phenomenon.
    Qunibi WY; Nolan CA; Ayus JC
    Kidney Int Suppl; 2002 Dec; (82):S73-80. PubMed ID: 12410860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survey of attitudes of physicians toward the current evaluation and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).
    Souqiyyeh MZ; Shaheen FA
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):93-101. PubMed ID: 20061700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Posttransplant regression of uremic tumoral calcinosis].
    de Alarcón RM; Palomares M; Marfil A; Asensio C
    Nefrologia; 2007; 27(3):378-81. PubMed ID: 17725459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of temporary metastatic pulmonary calcification in a patient with hyperparathyroidism on peritoneal dialysis.
    Kawase K; Takagi K; Mizuno M; Horie M
    Clin Nephrol; 2021 Mar; 95(3):161-165. PubMed ID: 33211001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of hyperparathyroidism.
    Davis PJ; Davis FB
    Otolaryngol Head Neck Surg; 1985 Feb; 93(1):62-4. PubMed ID: 2984631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regression of massive tumoral calcinosis of the ischium in a dialysis patient after treatment with reduced calcium dialysate and i.v. administration.
    Apostolou T; Tziamalis M; Christodoulidou C; Fountas P; Billis A
    Clin Nephrol; 1998 Oct; 50(4):247-51. PubMed ID: 9799070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.